Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites

A J Brown, H M Precious, J M Whitcomb, J K Wong, M Quigg, W Huang, E S Daar, R T D'Aquila, P H Keiser, E Connick, N S Hellmann, C J Petropoulos, D D Richman, S J Little

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites'. Together they form a unique fingerprint.

Medicine & Life Sciences

Agriculture & Biology